1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ATRNL1 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA FAM65A CTRPv2 pan-cancer AAC -0.11 0.001
mRNA MYL6 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA GATSL2 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA ACSL3 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA SYNE3 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA PRKRA CTRPv2 pan-cancer AAC 0.11 0.001
mRNA ZFP62 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA EXTL3 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA RALGAPA2 CTRPv2 pan-cancer AAC 0.11 0.001
Download CSV